Tyrian Trade

Morgan Stanley Reiterates $300 Price Target on $SPCX Ahead of 2027

Morgan Stanley analyst Adam Jonas reiterated an Overweight rating and $300 price target on SpaceX ($SPCX) on Nov. 13—representing roughly 116% upside from that day’s close around $138, even as shares traded 31% below their June peak and just 3% above the $135 IPO price.
Key takeaways from the note and recent company developments include:
- AI-driven valuation: Morgan Stanley attributes $170 of its $300 target to SpaceX’s enterprise AI business, with connectivity accounting for most of the remainder. Jonas noted that $SPCX trades at 17.6x 2028 adjusted earnings, slightly below the S&P 500’s 17.7x, while trading at roughly 51x 2027 earnings estimates.
- Mixed Starship test: Hours after the note, SpaceX’s attempt to catch the Super Heavy booster failed, resulting in an explosion in the Gulf of Mexico, though the spacecraft successfully reached orbit and deployed 26 Starlink satellites. Shares slipped 2% after hours.
- Heavy capital spending: Q3 revenue reached $14.6 billion—including $7.5 billion from its Super Intelligence unit—with $4.4 billion in earnings, but capital expenditures hit $19.6 billion and are projected to reach $35 billion to $40 billion in Q4. On Nov. 12, SpaceX also announced over $74 billion in data center projects in Texas and Arizona.
- Divided Wall Street outlook: While Raymond James initiated coverage at Strong Buy with an $800 target and the average analyst target stands at $256, skeptics such as NYU professor Scott Galloway and former Fidelity manager George Noble argue the stock is sharply overvalued.
Meanwhile, Bloomberg reported that SpaceX and Tesla ($TSLA) could announce a merger by December or early 2027, with Elon Musk stating both companies have formed independent board committees.

Morgan Stanley Reiterates $300 Price Target on $SPCX Ahead of 2027

Loading…